Rosiglitazone, a peroxisome proliferator-activated receptor-γ agonist, prevents microparticle-induced vascular hyporeactivity through the regulation of proinflammatory proteins

  1. Tesse, A.
  2. Al-Massarani, G.
  3. Wangensteen, R.
  4. Reitenbach, S.
  5. Martínez, M.C.
  6. Andriantsitohaina, R.
Zeitschrift:
Journal of Pharmacology and Experimental Therapeutics

ISSN: 1521-0103 0022-3565

Datum der Publikation: 2008

Ausgabe: 324

Nummer: 2

Seiten: 539-547

Art: Artikel

DOI: 10.1124/JPET.107.130278 GOOGLE SCHOLAR